Approvable letter
(Redirected from Non-approvable letter)
Approvable Letter is a formal document issued by regulatory authorities, such as the Food and Drug Administration (FDA), to a pharmaceutical company. The letter indicates that the agency has completed its review of the company's New Drug Application (NDA) or Biologics License Application (BLA) and that the application is approvable, pending the resolution of specific issues.
Overview[edit | edit source]
An approvable letter is not an approval. It is a communication from the FDA to the applicant stating that the agency is prepared to approve the application provided certain conditions are met. These conditions may include minor clarifications or additional analyses of existing data, but do not usually require new clinical trials.
Content of an Approvable Letter[edit | edit source]
The content of an approvable letter varies depending on the specific issues that need to be addressed. However, common elements include:
- A statement that the FDA has completed its review of the application.
- A list of specific issues that need to be resolved before approval can be granted.
- A request for additional information or clarification, if necessary.
- A statement that the FDA is prepared to approve the application if the issues are satisfactorily resolved.
Response to an Approvable Letter[edit | edit source]
Upon receipt of an approvable letter, the applicant has the opportunity to respond to the FDA's comments and provide the requested information. The FDA then reviews the response and, if satisfactory, issues an approval letter.
Impact of an Approvable Letter[edit | edit source]
The issuance of an approvable letter is a positive step towards the approval of a new drug or biologic. However, it does not guarantee approval. The applicant must satisfactorily address the issues raised in the letter before approval can be granted.
See also[edit | edit source]
- Complete response letter
- New Drug Application
- Biologics License Application
- Food and Drug Administration
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD